Document

Prospective Grant of Exclusive License: Uteroglobin in Treatment of IgA Mediated Autoimmune Disorders

[Federal Register Volume 65, Number 46 (Wednesday, March 8, 2000)] [Corrections] [Page 12318] From the Federal Register Online via the Government Publishing Office [ www.gpo.gov...

[Federal Register Volume 65, Number 46 (Wednesday, March 8, 2000)]
[Corrections]
[Page 12318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: C0-4009]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: Uteroglobin in Treatment 
of IgA Mediated Autoimmune Disorders

Correction

    In notice document 00-4009 beginning on page 8384 in the issue of 
Friday, February 18, 2000, make the following corrections:
    On page 8384, in the third column, seven lines from the bottom, the 
sentence should end, ``on or before May 18, 2000, will be considered.''

[FR Doc. C0-4009 Filed 3-6-00; 8:45 am]
BILLING CODE 1505-01-D


Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

65 FR 12056

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Prospective Grant of Exclusive License: Uteroglobin in Treatment of IgA Mediated Autoimmune Disorders,” thefederalregister.org (March 8, 2000), https://thefederalregister.org/documents/C0-4009/prospective-grant-of-exclusive-license-uteroglobin-in-treatment-of-iga-mediated-autoimmune-disorders.